ATE353544T1 - Verwendung des proteins masp als marker für kolorektale karzinome - Google Patents
Verwendung des proteins masp als marker für kolorektale karzinomeInfo
- Publication number
- ATE353544T1 ATE353544T1 AT04734663T AT04734663T ATE353544T1 AT E353544 T1 ATE353544 T1 AT E353544T1 AT 04734663 T AT04734663 T AT 04734663T AT 04734663 T AT04734663 T AT 04734663T AT E353544 T1 ATE353544 T1 AT E353544T1
- Authority
- AT
- Austria
- Prior art keywords
- masp
- marker
- colorectal carcinoma
- diagnosis
- colorectal cancer
- Prior art date
Links
- 206010009944 Colon cancer Diseases 0.000 title abstract 5
- 208000001333 Colorectal Neoplasms Diseases 0.000 title abstract 5
- 102000004528 Mannose-Binding Protein-Associated Serine Proteases Human genes 0.000 title abstract 4
- 108010042484 Mannose-Binding Protein-Associated Serine Proteases Proteins 0.000 title abstract 4
- 201000010989 colorectal carcinoma Diseases 0.000 title 1
- 239000003550 marker Substances 0.000 title 1
- 238000003745 diagnosis Methods 0.000 abstract 4
- 238000001514 detection method Methods 0.000 abstract 1
- 239000007788 liquid Substances 0.000 abstract 1
- 238000005259 measurement Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57419—Specifically defined cancers of colon
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/81—Protease inhibitors
- G01N2333/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Hospice & Palliative Care (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Oncology (AREA)
- Microbiology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP03011158 | 2003-05-26 | ||
| AT2004005598 | 2004-05-25 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE353544T1 true ATE353544T1 (de) | 2006-09-15 |
Family
ID=33462076
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT04734663T ATE353544T1 (de) | 2003-05-26 | 2004-05-25 | Verwendung des proteins masp als marker für kolorektale karzinome |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20060121540A1 (de) |
| EP (1) | EP1631826B1 (de) |
| JP (1) | JP4241822B2 (de) |
| CN (1) | CN100504393C (de) |
| AT (1) | ATE353544T1 (de) |
| CA (1) | CA2523690C (de) |
| DE (1) | DE602004001994T2 (de) |
| ES (1) | ES2271892T3 (de) |
| WO (1) | WO2004104593A1 (de) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2323429T3 (es) * | 2004-12-23 | 2009-07-15 | F. Hoffmann-La Roche Ag | Uso de la asc, como marcador para cancer colorrectal. |
| JP4606469B2 (ja) * | 2004-12-23 | 2011-01-05 | エフ．ホフマン−ラ ロシュ アーゲー | 直腸結腸癌用マーカーとしてのｃｙｆｒａ２１−１の使用 |
| WO2007040452A1 (en) * | 2005-10-04 | 2007-04-12 | Telefonaktiebolaget Lm Ericsson (Publ) | Paging for a radio access network having pico base stations |
| EP2680003A1 (de) * | 2012-06-28 | 2014-01-01 | Fundació Institut d'Investigació Biomèdica de Bellvitge | Serum-Biomarker zur Diagnose eines kolorektalen Karzinoms |
| ES2619116B1 (es) * | 2015-12-23 | 2018-04-12 | Fundación Para La Investigación Biomédica Del Hospital Universitario 12 De Octubre | Biomarcador para el diagnóstico, pronóstico y seguimiento de cáncer colorrectal de aparición precoz |
| CN107227366B (zh) * | 2017-07-05 | 2020-05-19 | 昆明医科大学第一附属医院 | 多功能转录调控因子ctcf的dna结合位点ctcf_113的应用 |
| CN108562746A (zh) * | 2018-04-08 | 2018-09-21 | 深圳市盛波尔生命科学技术有限责任公司 | Cnpy2异构体2在结直肠癌诊断、预后、复发转移及放化疗疗效预测中的应用 |
| GB201907663D0 (en) * | 2019-05-30 | 2019-07-17 | Ab Mavatar | Method for diagnosing colorectal cancer |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5470970A (en) * | 1991-02-28 | 1995-11-28 | Dana-Farber Cancer Institute, Inc. | Maspin, a serpin with tumor suppresing activity |
| US20020182191A1 (en) * | 1998-12-23 | 2002-12-05 | Corixa Corporation | Compounds for immunotherapy and diagnosis of colon cancer and methods for their use |
| AUPP713498A0 (en) * | 1998-11-17 | 1998-12-10 | Chandler, Howard Milne | A method of detecting blood |
-
2004
- 2004-05-25 AT AT04734663T patent/ATE353544T1/de active
- 2004-05-25 CN CNB2004800143194A patent/CN100504393C/zh not_active Expired - Fee Related
- 2004-05-25 DE DE602004001994T patent/DE602004001994T2/de not_active Expired - Lifetime
- 2004-05-25 WO PCT/EP2004/005598 patent/WO2004104593A1/en not_active Ceased
- 2004-05-25 CA CA2523690A patent/CA2523690C/en not_active Expired - Fee Related
- 2004-05-25 ES ES04734663T patent/ES2271892T3/es not_active Expired - Lifetime
- 2004-05-25 JP JP2006500105A patent/JP4241822B2/ja not_active Expired - Fee Related
- 2004-05-25 EP EP04734663A patent/EP1631826B1/de not_active Expired - Lifetime
-
2005
- 2005-11-23 US US11/287,575 patent/US20060121540A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| ES2271892T3 (es) | 2007-04-16 |
| EP1631826B1 (de) | 2006-08-16 |
| CN100504393C (zh) | 2009-06-24 |
| JP4241822B2 (ja) | 2009-03-18 |
| JP2006524794A (ja) | 2006-11-02 |
| WO2004104593A1 (en) | 2004-12-02 |
| EP1631826A1 (de) | 2006-03-08 |
| CN1795385A (zh) | 2006-06-28 |
| DE602004001994T2 (de) | 2007-09-13 |
| CA2523690C (en) | 2011-05-03 |
| DE602004001994D1 (de) | 2006-09-28 |
| CA2523690A1 (en) | 2004-12-02 |
| US20060121540A1 (en) | 2006-06-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE471512T1 (de) | Verwendung des proteins s100a 12 als marker für kolorektalkarzinom | |
| ATE554389T1 (de) | Apex als marker für lungenkrebs | |
| DE60315715D1 (de) | Verwendung von nicotinamide n-methyltransferase zur diagnose von kolorektalem krebs | |
| CY1112553T1 (el) | Ανοσοπροσδιορισμοι υψηλης ευαισθησιας και κιτια για τον προσδιορισμο πεπτιδιων και πρωτεϊνων βιολογικου ενδιαφεροντος | |
| ATE513216T1 (de) | Verwendung des proteins satb2 als prognostischer marker für kolorektalkarzinome | |
| CA2701341A1 (en) | Method of assessing colorectal cancer from a stool sample by use of the marker combination calprotectin and hemoglobin/haptoglobin complex | |
| ATE430936T1 (de) | Verwendung von cyfra 21-1 und osteopontin als marker für kolorektalkarzinome | |
| ATE468535T1 (de) | Verwendung von nnmt als marker für lungenkrebs | |
| ATE418072T1 (de) | Verfahren zur diagnose von gebärmutterhalskrebs | |
| DE602004017317D1 (de) | Verwendung der proteine proteinase 3 (prn3) und leukozyten elastatse inhibitor (ileu) als marker für kolorektale karzinome | |
| ATE353544T1 (de) | Verwendung des proteins masp als marker für kolorektale karzinome | |
| ATE462803T1 (de) | Kit und verfahren zum nachweis von urothelkarzinom | |
| ATE503846T1 (de) | Verfahren zur diagnose eines ovarialkarzinoms | |
| ATE534037T1 (de) | Verwendung des proteins asc als marker für brustkrebs | |
| ATE426168T1 (de) | Verwendung von asc als marker fur kolorektalkarzinome | |
| ATE359516T1 (de) | Verwendung des proteins crabp ii (cellular retinoic acid-binding protein ii) als marker für brustkrebs | |
| ATE531822T1 (de) | Diagnose von prostatakrebs | |
| ATE383418T1 (de) | Verfahren und zusammensetzungen zur bestimmung glycierter proteine | |
| ATE393393T1 (de) | Verwendung des proteins spee als marker für brustkrebs | |
| ATE418737T1 (de) | Verwendung des proteins spermidinsynthase (spee) als marker für kolorektalkarzinom | |
| ATE410691T1 (de) | Verwendung des proteins proteasome aktivator untereinheit 3 als marker für kolorektale karzinome | |
| DE602005014659D1 (de) | Auf immunreaktion gegen boris basierendes verfahren für den nachweis von krebs | |
| WO2005040807A3 (en) | Swiprosin-2 as a breast cancer marker | |
| WO2005124360A3 (en) | Use of protein tebp as a marker for breast cancer | |
| DE602006017228D1 (de) | Verfahren zur diagnose von tumoren durch messung des niveaus von apolipoprotein a-iv |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1631826 Country of ref document: EP |